Tenax Therapeutics (TENX) Raw Materials (2012 - 2014)

Tenax Therapeutics (TENX) reported Raw Materials of $28779.0 for Q1 2014, little changed on a YoY basis from $28779.0 in Q1 2013, and little changed sequentially from $28779.0 in Q4 2013.

Tenax Therapeutics (TENX) Raw Materials (2012 - 2014) Analysis & Trends

Tenax Therapeutics (TENX) has 3 years of Raw Materials data on file, last reported at $28779.0 in Q1 2014.

  • For the quarter ending Q1 2014, Raw Materials changed 0.0% year-over-year to $28779.0; the trailing twelve-month figure through Jan 2014 stood at $28779.0 (changed 0.0% YoY), and the FY2013 full-year result was $28779.0, up 12.51% from the prior year.
  • Raw Materials was little changed at $28779.0 in Q1 2014, from $28779.0 in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $38147.0 in Q3 2012 to a low of $25579.0 in Q2 2012.
  • A 3-year average of $29550.0 and a median of $28779.0 in 2012 frame the typical range for Raw Materials.
  • Peak annual rise in Raw Materials reached 12.51% in 2013, while the deepest fall reached 24.56% in 2013.
  • Tracing TENX's Raw Materials over 3 years: stood at $28779.0 in 2012, then changed by 0.0% to $28779.0 in 2013, then changed by 0.0% to $28779.0 in 2014.
  • Business Quant data shows TENX's Raw Materials at $28779.0 in Q1 2014, $28779.0 in Q4 2013, and $28779.0 in Q3 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Tenax Therapeutics 67,856.40 67,856.40 -

Historic Data

Download Data
DateValue
Jan 31, 2014 28,779.00
Oct 31, 2013 28,779.00
Jul 31, 2013 28,779.00
Apr 30, 2013 28,779.00
Jan 31, 2013 28,779.00
Oct 31, 2012 28,779.00
Jul 31, 2012 38,147.00
Apr 30, 2012 25,579.00